Hudson Bay Capital Management LP 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-10 6:58 pm Unchanged | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 76,598 4.990% | 0 (Unchanged) | Filing |
2025-02-10 4:24 pm Purchase | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 76,598 4.990% | 76,598![]() (New Position) | Filing |